Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

(ALNA)

0.075   0 (0%) 12-07 19:25
Open: Pre. Close:
High: Low:
Volume: 252,311,606 Market Cap: 0(M)

Technical analysis

as of: 2022-11-18 4:18:32 PM
Overall:       
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 0.11     One year: 0.17
Support: Support1: 0.01    Support2: 0.01
Resistance: Resistance1: 0.09    Resistance2: 0.14
Pivot: 0.07
Moving Average: MA(5): 0.07     MA(20): 0.05
MA(100): 0.08     MA(250): 0.24
MACD: MACD(12,26): 0     Signal(9): 0
Stochastic oscillator: %K(14,3): 47     %D(3): 47
RSI: RSI(14): 80.5
52-week: High: 0.77  Low: 0.01
Average Vol(K): 3-Month: 68,148 (K)  10-Days: 261,996 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ ALNA ] has closed below upper band by 43.3%. Bollinger Bands are 21.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.15 - 0.15 0.15 - 0.15
Low: 0.06 - 0.06 0.06 - 0.06
Close: 0.07 - 0.08 0.08 - 0.08

Company Description

Allena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. Its lead product candidate is ALLN-346, a novel and urate degrading enzyme for patients with hyperuricemia and gout in the setting of advanced chronic kidney disease. The company was incorporated in 2011 and is headquartered in Newton, Massachusetts.

Headline News

Wed, 07 Dec 2022
Volunteer Bulletin Board - The Lincoln County News

Wed, 07 Dec 2022
Lincoln County Sheriff's Report - The Lincoln County News

Wed, 07 Dec 2022
Wiscasset Police Report - The Lincoln County News

Tue, 06 Dec 2022
Aaron Miller leaving Livermore job to be Vassalboro town manager - Kennebec Journal and Morning Sentinel

Tue, 06 Dec 2022
Alna eyes March vote on apartments, short-term rentals - Wiscasset Newspaper

Thu, 01 Dec 2022
Alna Set for Special Town Meeting for Snowplow Contract - The Lincoln County News

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange: 
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 85 (M)
Shares Float 107 (M)
% Held by Insiders 1.1 (%)
% Held by Institutions 7.5 (%)
Shares Short 8,590 (K)
Shares Short P.Month 2,560 (K)

Stock Financials

EPS -1.01
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.43
Profit Margin (%) 0
Operating Margin (%) 0
Return on Assets (ttm) -96.1
Return on Equity (ttm) -278.2
Qtrly Rev. Growth 0
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -0.56
Qtrly Earnings Growth 0
Operating Cash Flow -56 (M)
Levered Free Cash Flow -38 (M)

Stock Valuations

PE Ratio -0.08
PEG Ratio 0
Price to Book value 0.17
Price to Sales 0
Price to Cash Flow -0.12

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.